Xiaohong Xia

机构：National Center for Clinical Laboratories, Jiangsu Province Hospital, Guangzhou Medical University Cancer Hospital, Nanjing Medical University, Guangzhou Medical University · ORCID：0000-0003-2219-1162

发表论文 70 篇 · 总被引 1690 次 · h-index 22

代表论文

• Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy (2020 · Theranostics · 被引 76)
• USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells (2021 · Journal of Experimental & Clinical Cancer Research · 被引 61)
• Inhibition of USP14 suppresses the formation of foam cell by promoting CD36 degradation (2020 · Journal of Cellular and Molecular Medicine · 被引 53)
• Deubiquitination of CD36 by UCHL1 promotes foam cell formation (2020 · Cell Death and Disease · 被引 51)
• The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression (2021 · Cell Death and Disease · 被引 46)
• A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance (2021 · Oncogene · 被引 43)